INTENSITY THERAPEUTICS, INC. Stockholders Equity

Quick Answer

INTENSITY THERAPEUTICS, INC. reported Stockholders Equity of $11.88 million for fiscal year 2025.

INTENSITY THERAPEUTICS, INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $11.88M +307.0%
2024 $2.92M -77.8%
2023 $13.16M +187.2%
2022 -$15.10M -73.8%
2021 -$8.69M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $7.22M +159.9% +230.7%
June 30, 2025 $2.18M -59.1% +553.9%
March 31, 2025 $334.0K -96.6% -88.6%
December 31, 2024 $2.92M -77.8% +5.0%
September 30, 2024 $2.78M -82.5% -48.0%
June 30, 2024 $5.34M -64.7% -45.0%
March 31, 2024 $9.72M +160.9% -26.1%
December 31, 2023 $13.16M +187.2% -17.3%
  • INTENSITY THERAPEUTICS, INC. showed an increase of +307.0% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2021–2025 period, INTENSITY THERAPEUTICS, INC.’s stockholders equity has grown by 236.7% (from -$8.69 million to $11.88 million).
  • The most recent figure is from INTENSITY THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment